The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder. Read more about The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder. Read more about Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.
Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes. Read more about Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes.
Questioning the New Drug Enforcement Administration Proposed Rule to Facilitate the Cultivation of Cannabis for Research Purposes. Read more about Questioning the New Drug Enforcement Administration Proposed Rule to Facilitate the Cultivation of Cannabis for Research Purposes.
Priority Considerations for Medicinal Cannabis-Related Research. Read more about Priority Considerations for Medicinal Cannabis-Related Research.
Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward. Read more about Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward.
A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members. Read more about A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members.
